CLINICAL_TRIALS
trial_result
· 2012-10-25
Clinical Trial Update: Treatment of Age-Related Macular Degeneration With Anecortave Acetate [Phase 2]
Summary
A Phase 2 clinical trial evaluating anecortave acetate for age-related macular degeneration has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Manhattan Eye, Ear & Throat Hospital | Conditions: Macular Degeneration | Phase 2 | Status: COMPLETED